WASHINGTON, June 9 -- Eli Lilly and Co. is urging the U.S. Department of Commerce to carefully consider the scope and impact of any potential tariffs stemming from its investigation into imported pharmaceuticals and ingredients. The pharmaceutical headquartered in Indianapolis, Indiana, emphasized its commitment to American manufacturing while cautioning against measures that could harm patient access and innovation. "While conducting this investigation and making his findings, we urge the Secr more ST

WASHINGTON, June 9 -- The U.S. Department of Commerce received a letter from California Life Sciences, Sacramento, California, highlighting concerns over a national security investigation into pharmaceutical imports. The organization, representing over 1,300 biotech entities, emphasized the need for a strategic approach to strengthen domestic biomanufacturing without disrupting global supply chains critical to innovation and patient care. Brent Fisk, senior vice president of government relation more ST